CDKN2A and cancer: Typically, this type of cancer is associated with a very heterogeneous tumour characterised by a high mutational burden (BRAF, NRAS, PTEN, TP53, and CDKN2A are the most frequently mutated genes), and because of this, it is considered a particularly aggressive type of cancer.